FibroBiologics issues warrant to holder
FibroBiologics issued a warrant granting the holder the right to subscribe for shares until September 2026 after a Securities Purchase Agreement. This document details the terms, exercise price, and voting rights associated with the financial instrument.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day